IOL master more accurate in silicone oil-filled eyes

Article

The IOL master is more accurate than A-scan immersion biometry in silicone oil (SO)-filled eyes.

The IOL master is more accurate than A-scan immersion biometry in silicone oil (SO)-filled eyes, claims a study in Eye.

Dr P. Kunavisarut et al., Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, conducted a prospective, consecutive, non-randomized investigation on 34 SO-filled eyes of 34 patients. All patients underwent a pars plana vitrectomy with SO removal and cataract surgery, as well as IOL implantation.

Axial length (AXL) was measured before SO removal using both A-scan immersion and IOL master. AXL was also measured three months after SO removal using IOL master. The accuracy of both techniques was determined by a mean postoperative AXL and reliability was determined by mean actual postoperative refractive error.

The preoperative mean AXL was 23.91±0.24 mm and 23.71±0.59 mm by the IOL master and A-scan immersion, respectively. The IOL master gave a postoperative mean AXL of 23.90±0.23 mm, which was statistically significant, compared with A-scan immersion.

At a range of −14.62 to 16.41 D predictive postoperative refractive error was greater in A-scan immersion, which was a statistically significant difference compared to the IOL master.

Overall, the IOL master is more accurate and has less deviation in predictive postoperative refractive error then A-scan immersion in SO-filled eyes.

The abstract can be read here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.